Back

SGLT2 inhibitors and anti-aldosterone agent combinations

18 May 2025 (16:00 - 16:15)
Organised by: Logo
Congress Presentation Part of: Innovative drug therapies in heart failure Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Shelley Zieroth

St. Boniface Hospital, University of Manitoba, Winnipeg (Canada)

3 More presentations in this session

Presentation thumbnail
Incretins
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
Treatment of iron deficiency
Doctor A. Oomman (Chennai, IN)
Slides Video
Presentation thumbnail
Anti-inflammatory agents
Doctor P. Jayagopal (Palakkad, IN)
Slides Video

Access the full session

Session thumbnail
Innovative drug therapies in heart failure
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 16:00 CET
You may be interested in
thumbnail
Congress Presentation
nsMRAs: what emerging trials tell us about the future of heart failure therapy
thumbnail
Congress Session
New frontiers in cardiovascular medicine: SGLT2/aldosterone synthase inhibition in heart failure treatment and prevention
thumbnail
Congress Session
A new era in the management of patients with heart failure: the role of non-steroidal MRAs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources